News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pernix Therapeutics, Inc. (PTX) Appoints Vice President Of Compliance


3/4/2014 8:24:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced the appointment of Jessica Oien as Vice President of Compliance.

“As we continue to focus on growing our business in the U.S., it is a key corporate objective to add seasoned executives in critical areas,” said Doug Drysdale, Pernix’s President and Chief Executive Officer. “Jessica is an accomplished executive with a solid track record of executing successful corporate compliance programs. Jessica will be responsible for overseeing Pernix’s global compliance program.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES